European Journal of Nuclear Medicine and Molecular Imaging 2004: Vol 31 Table of Contents

2004·4.9 MB·English

European Journal of
Nuclear Medicine
and Molecular Imaging Founded in 1975
Editors-in-Chief
H. Hundeshagen Vol. 1—15 (1976-1989);
Official Journal of the European Association ¢of Nuclear Medicine (EANM) Vol. 16-30 (1990-2003) P.J. Ell;
up from Vol. 32 (2004) F. Carrio
Contents of Volume 31 - 2004
Acampa W — Petretta M Armbrust-Henrich H > Schreckenberget M Bartenstein P — Helisch A
Ageyeva L — Ponomarev V Arndt J-W — Soerdjbalie-Maikoe V Bartenstein P — Schreckenberger M
Ahn JM — Muhle C Arnold R — Helisch A Bartolomei M — Bodei L
Aide N — Grahek D Arslan N — Ilgan S Bauer A — Weber S
Airaksinen KEJ — Knuuti J Arslandemir C — Schirrmeister H Bax KEJJ — Knuuti J
Akesson L — Svensson A Arulampalam TH — Francis DL Becherer A — Zettinig G
Al-Mohammad A — Underwood SR Asada T — Kanetaka H Becker GA — Reimold M
AL-Nahhas A — Webb M Assmus B — Dobert N Bedford M, Maisey MN: Requirements
Aloj L, Zannetti A, Caracé C, Aston JAD — Turkheimer FE for clinical PET: comparisons within
Del Vecchio S, Salvatore M Atac GK — Ilgan S Europe 208
Bcl-2 overexpression prevents Audenaert K — Goethals I| Beekman FJ — Bokulié 1
Tc-MIBI uptake in breast cancer cell Aydogdu I — Argon M Been LB, Suurmeijer AJH, Cobben DCP.
lines 521 Jager PL, Hoekstra HJ, Elsinga PH:
Alonso-de-Ruiz P > Hurtado-Lopez LM Baars PC > Valdés Olmos RA |'SF]FLT-PET in oncology: current
Ametamey SM — Wyss MT Babin E > Berthe E status and opportunities 1659
Amon M — Samnick S Bading JR — Chen X Begent RHJ — Francis RJ
Amthauer H, Denecke T, Rau B, Baehre M — Meller B Behin-Ain S — Barnden LR
Hildebrandt B, Hiinerbein M, Ruf J, Bai J, Yokoyama K, Kinuya S, Shiba K, Bellandi F — Leoncini M
Schneider U, Gutberlet M, Schlag PM, Matsushita R, Nomura M, Michigishi T, Bender H — Matthies A
Felix R, Wust P: Response prediction Tonami N: In vitro detection of mdr1 Bengel FM: Is the future of nuclear
by FDG-PET after neoadjuvant mRNA in murine leukemia cells with medicine written in the genes? 309
radiochemotherapy and combined In-labeled oligonucleotide 1523 Bengel FM — Pirich C
regional hyperthermia of rectal cancer Bai J — Kinuya S Bentzen L — Grénroos T
correlation with endorectal ultrasound Balatoni J — Ponomarev V Beresten T — Ponomarev \
and histopathology 811 Ballinger JR — O’ Mahony S$ Bernal P — Sundram F
Amthauer H, Ruf J, Bohmig M Balzarini L — Malesci A Berner U — Dobert N
Lopez-Hanninen E, Rohlfing 1 Bammer H — Bettinardi V Bernhardt P — Forrer F
Wernecke K-D, Pléckinger | Bang LE — Hesse B Bertagna F — Giubbini R
Gutberlet M, Lemke A-J, Steinmiiller T Barber RW —O 'Mahony S Berthe E, Henry-Amar M, Michels J-J,
Wiedenmann B, Felix R: Diagnosis Bardet S — Berthe E Rame J-P, Berthet P, Babin E, Icard P,
of neuroendocrine tumours by Bares R — Reimold M Samama G, Galateau-Sallé F,
retrospective image fusion: is there Bares R — Smyczek-Gargya B Mahoudeau J, Bardet S: Risk of second
a benefit? 342 Barnden LR, Hatton RL, Behin-Ain S, primary cancer following differentiated
Anagnostopoulos C — Underwood SR Hutton BF, Goble EA: Optimisation thyroid cancer 685
Ando A — Nanasato M of brain SPET and portability of normal Berthet P — Berthe E
Andreo P > Sanchez-Crespo \ databases 378 Bettinardi V, Danna M, Savi A, Lecchi M,
Angelides S — Hatton RI Barrington SF, Chambers J, Hallett WA, Castiglioni I, Gilardi MC, Bammer H,
Annovazzi A — Signore A O'Doherty MJ, Roxburgh JC, Lucignani G, Fazio F: Performance
Antoch G — Freudenberg LS Nunan TO: Comparison of sestamibi, evaluation of the new whole-body
Antoniucci D — Sciagra R thallium, echocardiography and PET PET/CT scanner: Discovery ST 867
Aoi T —Z eniya T for the detection of hibernating Bettinardi V — Pelosi E
Arellano-Montano S myocardium 355 Bettman L — Tharp K
+ Hurtado-Lopez LM Bar-Shalom R, Gaitini D, Keidar Z, Beyer G-J, Miederer M, VranjeS-Duric S,
Argon M, Secil Y, Duygun , Aydogdu I, Israel O: Non-malignant FDG uptake Comor JJ, Kiinzi G, Hartley O,
Kocacelebi K, Ozkilic H, Ertekin C in infradiaphragmatic adipose tissue: Senekowitsch-Schmidtke R, Soloviev D,
The value of scintigraphy in the a new site of physiological tracer Buchegger F, and the ISOLDE
evaluation of oropharyngeal dysphagia biodistribution characterised by PET/CT Collaboration: Targeted alpha therapy
94 1105 in vivo: direct evidence for single
cancer cell kill using '*’Tb-rituximab outcome in chondrosarcoma patients Cerqueira M — Underwood SR
547 189 Chambers A — Webb M
Beyer T — Freudenberg LS Brenner W, Vernon C, Conrad EU, Eary JF Chambers J — Barrington SF
Bhatia J — Francis RJ Assessment of the metabolic activity of Chan S-C — Ng S-H
Bhatnagar A — Sarin B bone grafts with '*F-fluoride PET 1291 ( ‘hang JT-C — Ng S-H
Biederer J] — Muhle ¢ Brenner W — Muhle C ( ‘hang Y-C — Ng S-H
Biersack H-J — Matthies A Bril H — Soerdjbalie-Maikoe V ( ‘hapman JD — Zanzonico P
Birchall JD, Blackband K, Freeman BJ Brink I, Schumacher T, Mix M, Ruhland §S, ( ‘hatal J-F > Couturier O
Ganatra RH, O'Leary M, Perkins AC Stoelben E, Digel W, Henke M, Chatziioannou AF > Inubushi M
Precise localisation of osteoblastoma Ghanem N, Moser E, Nitzsche El ( ‘hau TCM — Sundram F
with SPET/CT 308 Impact of |'*F]FDG-PET on the primary ( ‘hen C-Y — Huang W-S
Bischof Delaloye A, Hojgaard L, Knuuti J staging of small-cell lung cancer 1614 ( ‘hen J — Zhang X
Peter Ell: portrait of an Editor 3 Britten M — Débert N ( ‘hen L-K — Wu T-H
Blackband K — Birchall JD Brogsitter C, Wonsak A, Wiirl K, ( hen X, Park R, Hou Y, Khankaldyyan V,
Blankenberg FG — Mari ¢ Kotzerke J: Peritoneal strumosis 1057 Gonzalez-Gomez I, Tohme M,
Blasberg R — Ponomarev \ Brown-Proctor C — Clark PB Bading JR, Laug WE, Conti PS
Blasberg R > Sasajima T Bruggemann JM, Som SS, Lawson JA, MicroPET imaging of brain tumor
Blasberg R — Wen B Haind! W, Cunningham AM, Bye AMI angiogenesis with !*F-labeled
Bleeker-Rovers CP, Kleijm EMHA de Application of statistical parametric PEGylated RGD peptide 1081
Corstens FHM, Meer JWM van der, mapping to SPET in the assessment ‘hen Y — Zanzonico P
Oyen WJG: Clinical value of FDG PET of intractable childhood epilepsy 369 ‘hester K — Francis RJ
in patients with fever of unknown origin Brunkhorst T — Otto D ‘hilvers AJ — O’ Mahony S
and patients suspected of focal infection Buchegger F — Beyer G-J ‘hinol M — Bodei L
or inflammation 29 Buchheimer N — Clark PB ‘hiti A — Malesci A
Blohmer J-U — Maza S Buchholz H-G — Helisch A ‘hoe YS — Lee K-H
Blond S — Prigent-Le Jeune | Buchholz H-G — Schreckenberger M ‘hoi JH — Lee K-H
Bockisch A — Freudenberg LS Buck \ > Schirrmeister H ‘hoi Y —~ Lee JD
Bode B — Wyss MT Buck A > Wyss MT ‘hoi Y-H — Lee JD
Bodei L, Cremonesi M, Grana C, Rocca P Buell | > Lipke CSA ‘holewinski W, Kowalczyk JR
Bartolomei M, Chinol M, Paganelli G Buell | > Reinartz P Stefaniak B, Stefaniak J,
Receptor radionuclide therapy Buist MR > Pijpers R Poniatowicz-Frasunek E, Tarkowska A
with “’Y-[DOTA] Tyr octreotide Burgman P > Wen B Diagnosis and staging of children’s
(Y-DOTATOC) in neuroendocrine Burroni L — Pacini F lymphoma using the technetium
tumours 1038 Busemann Sokole I > Visser JJN labelled somatostatin analogue,
Bodei L — Lazzeri I Bye AME > Bruggemann JM "™Te-depreotide 818
Boellaard R > Joshi | Byun SS > I ec K-H ‘hoong KKL — Hatton RI
Boellaard R > Verel | ‘hu T-C —W u T-H
Boerner AR — Otto D aiS ~ Wen B ‘hugh PK — Sarin B
Bogsrud T — Seierstad T ai S — Zanzonico P Chung J-K, Kang JH rranslational
Bohmig M — Amthauer H ‘alles-Escandon J > Clark PB research using the sodium/iodide
Bokuli¢ T, Vastenhouw B, Jong HWAM de amacho V, Estorch M, Fraga G, symporter in imaging and therapy 799
Dongen AJ van, Rijk PP van Mena E, Fuertes J, Hernandez MA, ‘hung J-K — Kang WJ
Beekman FJ: Monte Carlo-based Flotats A, Carrié I: DMSA study ‘hung J-K — Kim S
down-scatter correction of SPECT performed during febrile urinary tract ‘hung J-K — Shin JH
attenuation maps 1173, 1451 infection: a predictor of patient ‘iprian A — De Cicco C
Bommer M > Schirrmeister H outcome? 862 ‘juoli C — Pacini F
Borght TV > Tang B-N-T ‘amacho V >» Estorch M ‘lark PB, Gage HD, Brown-Proctor C,
Bormans G — Van Laere K ‘amacho V > Mena E Buchheimer N, Calles-Escandon J,
Bornmann W — Ponomarev \ anclini S » Giubbini R Mach RH, Morton KA: Neurofunctional
Bosio G — Giubbini R ‘apoccetti F —> Schillaci O imaging of the pancreas utilizing
Bosly A — Krug B ‘arac6éC > Aloj I the cholinergic PET radioligand
Bosson P — Ryding f ‘arriéI : Reflections after | year online |'SF]4-fluorobenzyltrozamicol 258
Botton: A — Lazzeri I 1569 ‘leynhens J > Van Laere K
Bourguet P — Garin I ‘arrio |: The EJNM, an integrative vehicle ‘lotagatide A -~ Denoyer D
Bouterfa H — Helisch A for information transfer in nuclear ‘obben DCP > Been LB
Brack SS, Dinkelborg LM, Neri D medicine and molecular imaging | ‘omans EF — Herder GJ
Molecular targeting of angiogenesis arrio | > Camacho V ‘omans EFI — Joshi |
for imaging and therapy 1327 ‘arrio | > Mena E ‘omis G > Sciagra R
Bracke M — Van Den Bossche B arrio | » Estorch M ‘omor JJ > Beyer G-J
Bradvik B — Ryding E ‘astel T » Vidal-Sicart S AArFR‘ARrRo nrad EU > Brenner W
Brand J-M — Meller B ‘astell-Conesa J + Lorenzo-Bosquet C Consoli V > Lazzeri E
Brenner W, Conrad EU, Eary JF: FDG PET ‘astiglioni | > Bettinardi V Conti PS > Chen X
imaging for grading and prediction of ‘aulet-Maugendre S — Garin E Coppola A > Leoncini M
Corstens FHM — Bleeker-Rovers CP Decristoforo C — Gabriel M Dongen AJ van — Bokuli¢ T
Costa DC — Francis DL Deiana L — Piga M Dongen GAMS van — Verel I
‘osta DC — Visvikis D Deichen JT, Schmidt C, Prante O, Donnemiller E — Gabriel M
‘outurier O, Luxen A, Chatal J-F, Maschauer S, Papadopoulos T, Dou S — Liu G
Vuillez J-P, Rigo P, Hustinx R Kuwert T: Influence of TSH on uptake Doubrovin M — Ponomarev V
Fluorinated tracers of imaging cancer of [|'*F]fluorodeoxyglucose in human Dreinhéfer K — Schirrmeister H
with positron emission tomography thyroid cells in vitro 507 D’haeninck E — Van Den Bossche B
1182 Del Maschio A — Pelosi E Duarte-Torres RM — Hurtado-L6pez LM
‘remonesi M — Bodei L Del Vecchio S —~ Aloj L Dubois F — Denoyer D
‘remonesi M > Forrer F Delbeke D — Tharp K Dubois F — Prigent-Le Jeune F
‘ristofani R > Lazzeri E Demidov VV — He Y Dudezak R — Zettinig G
‘roasdale | — Francis DL Denecke T — Amthauer H Dunkelmann S, Wolf R, Koch A, Kittner C,
roasdale | — Visvikis D Deng W-P, Yang WK, Lai W-F, Liu R-S, Groth P, Schuemichen C: Incidence
‘ross AJ — Kung M-P Hwang J-J, Yang D-M, Fu Y-K, of radiation-induced Graves’ disease
unningham AM > Bruggemann JM Wang H-E Non-invasive in vivo in patients treated with radioiodine for
unningham VJ > Turkheimer FE imaging with radiolabelled FIAU thyroid autonomy before and after
‘uocolo A — Imbriaco M for monitoring cancer gene therapy introduction of a high-sensitivity TSH
‘uocolo A — Petretta M using herpes simplex virus type | receptor antibody assay 1428
uvelier C > Vermeersch H thymidine kinase and ganciclovir 99 Dupont P — Van Laere
~AAAA ‘RRz eAchA RNA A>A MAuAhlReD AC Denoyer D, Perek N, Jeune NL, Frere D, Duygun — Argon M
Sabido O, Clotagatide A, Dubois F
Dabizzi RP > Leoncini M In vitro and in vivo evaluation of the Eary JF — Brenner W
Dahibom M — Inubushi M influence of type II] NaPi co-transporter Eck-Smit BLF van — Visser JJN
Daitzchman M — Tharp K activily during apoptosis on :denbrandt L — Svensson A
Daldrup-Link HE, Rudelius M, Metz S, s”’™Tc-(V)DMSA uptake in the human sigtved A — Kjaer A
Piontek G, Pichler B, Settles M, leukaemic cell line U937 1421 ‘isenhut M — Henze M
Heinzmann U, Schlegel J, Denoyer D, Perek N, Le Jeune N, ‘11 PJ — Francis DL
Oostendorp RAJ, Rummeny EJ Frere D, Dubois F: Evidence that sll PJ —-» Underwood SR
Cell tracking with gadophrin-2 mTc-(V)-DMSA uptake is mediated 311 PJ — Visvikis D
a bifunctional contrast agent for MR by NaPi cotransporter type II] in tumour ‘lsinga PH — Been LB
imaging, optical imaging, and cell lines indo K — Tian M
fluorescence microscopy 1312 Di Cairano G > Pacini F tngblom E — Knuuti J
Danieli R — Schillaci O Di Liberto M > Piga M nsinger C — Gabriel M
Danna M — Bettinardi \V Dierck RA > Vermeersch H irba PA — Lazzeri E
Das BK, Senthilnathan MS, Pradhan PK, Dierckx R > De Man S irselcan T, Sungu S, Ozdemir S,
Nagabhushan §S, Jeloka TK, Dierckx R > Goethals | Turgut B, Dogan D, Ozdemir O:
Sharma RK: Comparison of peritoneal Dierckx R > Jacobs F lodine-131 treatment and chromosomal
equilibration test with mTe-DTPA Dierckx RA > De Winter F damage: in vivo dose-effect
excretion in the assessment of peritoneal Dierckx RA > Lahorte CMM relationship 676
permeability 710 Dierckx RA > Van Den Bossche B {rtekin C — Argon M
De Bast M — Mahy P Diest PJ van > Pijpers R {skola O — Grénroos 1
De Ceuninck L — Van Laere K Digel W — Brink I tstorch M, Carrié I, Mena E, Flotats A,
De Cicco C, Trifird G, Intra M, Marotta G, Dijkstra J — Pijpers R Camacho V, Fuertes J, Kulisewsky J,
Ciprian A, Frasson A, PriscoG , Dimitrakopoulou-Strauss A > Henze M Narula J: Challenging the neuronal
Luini A, Viale G, Paganelli G Dimmeler S — Débert N MIBG uptake by pharmacological
Optimised nuclear medicine method Dinkelborg LM — Brack SS intervention: effect of a single dose of
for tumour marking and sentinel node Dittmann H — Smyczek-Gargya B oral amitriptyline on regional cardiac
detection in occult primary breast Dobbeleir A — Hambye A-S MIBG uptake 1575
lesions 349 Débert N, Britten M, Assmus B, Berner U, istorch M — Camacho V
De Man S, Gemmel P, Vlerick P, Menzel C, Lehmann R, Hamscho N, istorch M — Mena E
Dierckx R: Waiting for Godot: waiting Schichinger V, Dimmeler S, vangelista L — Petretta M
in nuclear medicine 1572 Zeiher AM, Griinwald F: vans SG, Hutton BF: Variation in
De Santis R — Paganelli G Transplantation of progenitor cells after scanning line source sensitivity:
De Vos F — Van Den Bossche B reperfused acute myocardial infarction: a significant source of error in
De Winter F, Gemmel F, Van Laere K, evaluation of perfusion and myocardial simultaneous emission-transmission
De WinterO , Poffijn B, Dierckx RA, viability with FDG-PET and thallium tomography 703
Van de Wiele C : *™Tc-Ciprofloxacin SPECT 1146 :zziddin S — Matthies A
planar and tomographic imaging Dodig D — Hui¢ D
for the diagnosis of infection in the Dogan D — Erselcan T Fang W — Zhang X
postoperative spine: experience in 48 Dohmen BM — Reimold M Fang Y-H, Kao T, Liu R-S, Wu L-C:
patients 233 Dohmen BM — Smyczek-Gargya B Estimating the input function
De Winter O — De Winter F Doi A — Matsuki 1 non-invasively for FDG-PET
Debatin JF — Freudenberg LS Dom R — Van Laere K quantification with multiple linear
regression analysis: simulation and Fujimoto S, Inoue A, Hisatake S, after coronary artery bypass grafting
verification with in vivo data 692 Yamashina S, Yamashina H, Nakano H, 137]
Fazio I > Bettinardi V Yamazaki J: Usefulness of Glatting G — Schirrmeister H
Fazio F — Pelosi E *3]-metaiodobenzylguanidine Goble EA — Barnden LR
Feiden W — Samnick S myocardial scintigraphy for predicting Goethals I, Audenaert K, Van de Wiele C,
Felix R — Amthauer H the effectiveness of 6-blockers in Dierckx R: The prefrontal cortex
Ferro A — Imbriaco M patients with dilated cardiomyopathy insights from functional neuroimaging
Fersis N — Smyczek-Gargya B from the standpoint of long-term using cognitive activation tasks 408
Finn R > Sasajima 1 prognosis 1356 Goethals I — Jacobs F
Finn R > Verel | Fujita M, Varrone A, Kim KM, Watabe H, Goéke B — Helisch A
Finn R » Wen B Zoghbi SS, Seneca N, Tipre D, Golding RP — Herder GJ
Finn R > Zanzonico P Seibyl JP. Innis RB, lida H: Effect G6émez-Rio M, Martinez del Valle Torres D,
Flint EJ » Underwood SR of scatter correction on the Rodriguez-Fernandez A,
Flotats A > Camacho \ compartmental measurement of striatal Llamas-Elvira JM, Lozano SO
Flotats A > Estorch M and extrastriatal dopamine D, receptors Font CR, Lopez Ramirez E, Katati M
Flotats A — Mena I using |'**I]epidepride SPET 644 TI-SPECT in low-grade gliomas
Font CR — Gomez-Rio M Fukuda H — Kubota K diagnostic accuracy in differential
Forrer F, Uusijairvi H, Waldherr C Fukuda Y — Horiuchi-Suzuki K diagnosis between tumour recurrence
Cremonesi M, Bernhardt P. Fukuhara R —~ Nagao M and radionecrosis 1237
Mueller-Brand J, Maecke HR: A Futatsubashi M — Torizuka 1 Gonzalez-Gomez | > Chen X
comparison ol In-DOTATOC and Gorges R > Freudenberg LS
In-DOTATATI biodistribution Gabriel M, Froehlich F, DecristoforoC , Goris ML — Mari C
and dosimetry in the same patients with Ensinger C, Donnemiller E, Gétz C — Pépperl G
metastatic neuroendocrine tumours Guggenberg E von, Heute D, Grabowski M — Ryding E
1257 Moncayo R: ”%"Tc-EDDA @HYNIC Grahek D, Montravers F, Kerrou K,
Forster GJ > Helisch A TOC and '*F-FDG in thyroid cancer Aide N, Lotz J-P, Talbot J-N: ['SF]FDG
Fraga G >» Camacho V patients with negative '*'l whole-body in recurrent breast cancer: diagnostic
Francis D — Visvikis D scans 330 performances, clinical impact and
Francis DL, Visvikis D, Costa DC Gage HD — Clark PB relevance of induced changes in
Croasdale |, Arulampalam TH Gaitini D — Bar-Shalom R management 179
Luthra SK, Taylor |, Ell PJ Assessment Galalae R — Muhle C Grana C > Bodei |
of recurrent colorectal cancer following Galateau-Sallé F — Berthe E Green AJ > Francis RJ
5-fluorouracil chemotherapy using Ganatra RH — Birchall JD Gregoire V >» Mahy P
both '*FDG and '*FLT PET 928 Gao R — Zhang X Grénroos T, Bentzen L, Marjamiaki P.
Francis RJ, Mather SJ, Chester K Gardner A — Pagani M Murata R, Horsman MR, Keiding S,
Sharma SK, Bhatia J, Pedley RB, Garin I Noiret N, Malbert C, Lepareur N Eskola O, Haaparanta M, Minn H,
Waibel R, Green AJ, Begent RHJ Roucoux A, Caulet-Maugendre S, Solin O: Comparison of the
Radiolabelling of glycosylated Moisan A, Lecloirec J, Herry Vy biodistribution of two hypoxia markers
MFE-23::CPG2 fusion protein Bourguet P: Development and |'SFIFETNIM and |'*F]FMISO in an
(MFECP1) with Ic for quantitation biodistribution of '**Re-SSS lipiodol experimental mammary carcinoma 513
of tumour antibody-enzyme following injection into the hepatic Groshar D — Sopov V
localisation in antibody-directed artery of healthy pigs 542 Groth P — Dunkelmann S$
enzyme pro-drug therapy (ADEPT) Garrigues V > Ponce J Griinder G — Schreckenberger M
1090 Gelovani J > Wen B Griinwald I > Dobert N
Frank J > Webb M Gelovani JG > Sasajima T Grupe P > Johansen A
Frasson A > De Cicco( Gelovani Tjuvajev J > Ponomarev V Guarino f > Pacini I
Freeman BJ > Birchali JD Gemmel I > De Winter F Guggenberg E von > Gabriel M
Freiberg J — Hove JD Gemmel P » De Man S Guhlke S > Matthies A
Frere D — Denoyer D George J > Tang B-N-T Guillou | > Reubi JC
Freudenberg LS, Antoch G, Schiitt P. Germano G > Giubbini R Gunalp B > Iigan S
Beyer T, Jentzen W, Miiller SP. Gerweck I > Zanzonico P Gupta S ~ LiuG
Gérges R, Nowrousian MR Geworski I > MazaS Guski H — Maza S$
Bockisch A, Debatin JF: FDG-PET/CT Ghanem N > Brink | Gutberlet M — Amthauer H
in re-staging of patients with lymphoma Gianolli I - Pelosi I
325
Gilardi MC > Bettinardi V Haaparanta M > Gronroos T
Friedman HS — Vaidyanathan G Gilardi MC > Pelosi E Haberkorn U — Henze M
Froehlich F — Gabriel M Gildehaus F-J — Poépperl G Haber! R — Pirich C
Frohn C — Meller B Gillart J - Mahy P Habraken JBA — Visser JIN
Fu Y-K — Deng W-P Giubbini R, Rossini P, Bertagna F, Bosio G Hiigele S — Schreckenberger M
Fuertes J — Camacho V Paghera B, Pizzocaro C, Canclini S, Hahn K, Pfluger T: Has PET become
Fuertes J > Estorch M Terzi A, Germano G: Value of gated an important clinical tool in paediatric
Fuertes J >» Mena I SPECT in the analysis of regional wall imaging? 615
Fuertes S > Vidal-Sicart S motion of the interventricular septum Haind! W — Bruggemann JM
Vu
Hallett WA — Barrington SF HerderGJ , Golding RP, Hoekstra OS, Hojgaard L — Kjaer A
Hiallstré6m T — Pagani M Comans EF, Teule GJ, Postmus PE, Huang W-S, Lee M-S, Lin J-C, Chen C-Y,
Ham H — Jacobs F Smit EF: The performance of Yang Y-W, Lin S-Z, Wey S-P:
Hambye A-S, Vervaet A, Dobbeleir A 'SF-fluorodeoxyglucose positron Usefulness of brain °°™Tc-TRODAT- |
Variability of left ventricular ejection emission tomography in small solitary SPET for the evaluation of Parkinson's
fraction and volumes with quantitative pulmonary nodules 1231 disease 155
gated SPECT: influence of algorithm, Hernandez MA — Camacho V Huang W-S — Lee J-K
pixel size and reconstruction parameters Herry JY — Garin E Huang Y-H — Wu T-H
in small and normal-sized hearts 1606 Hesse B, Meyer C, Nielsen FS, Sato A, Huic D, Labar B, Hui¢ M, Radman I,
Hamdy NAT — Soerdjbalie-Maikoe V Hove JD, Holm S, Bang LE, Dodig D, Mrsi¢ M: Splenectomy?
Hamscho N — Débert N Kofoed KF, Svendsen TL, Parving H-H, No, thank you? 1677
Han K-H — Lee JD Opie LH: Myocardial perfusion in Huic M — Hui¢é D
Harbinson M — Underwood SR type 2 diabetes with left ventricular Humm J — Zanzonico P
Hartley O — Beyer G-J hypertrophy: normalisation by acute Hiinerbein M — Amthauer H
Hashimoto K — Horiuchi-Suzuki K angiotensin-converting enzyme Hurtado-Lépez LM, Arellano-Montaii S,
Hatton RL, Hutton BF, Angelides S, inhibition 362 Torres-Acosta EM, Zaldivar-Ramirez FR,
Choong KKL, Larcos G: Improved Hetzel M — Schirrmeister H Duarte-Torres RM, Alonso-de-Ruiz P,
tolerance to missing data in myocardial Heute D — Gabriel M Martinez-Duncker I,
perfusion SPET using OSEM Higashi K, Ueda Y, Matsunari I, Kodama Y, Martinez-Duncker C: Combined use
reconstruction 857 Ikeda R, Miura K, Taki S, Higuchi T, of fine-needle aspiration biopsy, MIBI
Hatton RL — Barnden LR Tonami H, Yamamoto I: ''C-acetate scans and frozen section biopsy offers
Haus U — Helisch A PET imaging of lung cancer the best diagnostic accuracy in the
Hauschild M — Maza S comparison with 'SF-FDG PET and assessment of the hypofunctioning
Hauser A — Henriksen G "m™Tc-MIBI SPET 13 solitary thyroid nodule 1273
Hausmann J — Tharp K Higashi T — Iwata M Hustinx R — Couturier O
Hayashi T — Zeniya 1 Higuchi T — Higashi K Hiittner C — Maza S
Hayashida K — Ito H Higuchi T — Tian M Hutton BF — Barnden LR
He J —~ LiuG Hildebrandt B — Amthauer H Hutton BF — Evans SG
He Y, Panyutin IG, Karavanov A, Hirahara F — Suzuki A Hutton BF — Hatton RL
Demidov VV, Neumann RD Hirayama H — Nanasato M Hwang J-J — Deng W-P
Sequence-specific DNA strand cleavage Hisatake S — Fujimoto S
by '!'In-labeled peptide nucleic acids Hnatowich DJ — Liu G Icard P — Berthe E
837 Hoefnagel CA — Valdés Olmos RA Ichise R — Murakami Y
He Z-X — Zhang X Hoekstra HJ — Been LB lida A — Ito H
Heeman PM — Visser JJN Hoekstra OS — Herder GJ lida H — Fujita M
Heinzmann U — Daldrup-Link HE Hoekstra OS — Joshi | lida H —~ Hove JD
Helisch A, Férster GJ, Reber H Hof K von — Meller B lida H — Zeniya T
Buchholz H-G, Arnold R, Goke B, Hofmann M — Meyer G-J lida Y — Iwata M
Weber MM, Wiedenmann B, Pauwels S, Hofmann M — Otto D Ikeda M — Nagao M
Haus U, Bouterfa H, Bartenstein P Hoft S —~ Muhle ¢ Ikeda R — Higashi K
Pre-therapeutic dosimetry and Hokoishi K — Nagao M Iigan S, Karacalioglu AO, Pabuscu Y,
biodistribution of °°Y-DOTA-Phe Holm S — Hesse B Atac GK, Arslan N, Ozturk E,
[yr’-octreotide versus Holm S — Hove JD Gunalp B, Ozguven MA: lodine-131
In-pentetreotide in patients with Honer M — Wyss MT treatment and high-resolution CT
advanced neuroendocrine tumours Hong M-K — Park S-W results in patients with lung metastases
1386 Horenblas S — Valdés Olmos RA from differentiated thyroid carcinoma
Hellwig D — Samnick S Horiuchi-Suzuki K, Konno A, Ueda M, 824
Henke M — Brink I Fukuda Y, Nishio S, Hashimoto K, Imabayashi E — Kanetaka H
Henriksen G, Schottelius M, Poethko T, Saji H: Skeletal affinity of Te(V)-DMS Imbriaco M, Ferro A, StortoG , Pellegrino T,
Hauser A, Wolf 1, Schwaiger M is bone cell mediated and pH dependent Sica G, Cuocolo A: Early and late effects
Wester H-J: Proof of principle for 388 of coronary artery bypass grafting on
the use of ''C-labelled peptides in Horsman MR — Gronroos 1 cardiac haemodynamics during daily
tumour diagnosis with PET 1653 Hou C — Kung M-P physical activities in patients with
Henry-Amar M — Berthe E Hou Y — Chen X coronary artery disease 852
Henze E — Muhle C Hove JD, lida H, Kofoed KF, Freiberg J, Imperiale A — Sciagra R
Henze M, Schuhmacher J, Holm S, Kelbaek H: Left atrial versus Innis RB — Fujita M
Dimitrakopoulou-Strauss A, left ventricular input function for Inoue A — Fujimoto S
Strauss LG, Micke HR, Eisenhut M, quantification of the myocardial blood Inoue H — Kaji T
Haberkorn U: Exceptional increase flow with nitrogen- 13 ammonia and Inoue T — Kawano T
in somatostatin receptor expression positron emission tomography 71 Inoue T — Suzuki A
in pancreatic neuroendocrine tumour, Hove JD — Hesse B Intra M — De Cicco C
visualised with **Ga-DOTATOC PET Hgilund-Carlsen PF — Johansen A Inubushi M, Jordan MC, Roos KP.
466 Hojgaard L — Bischof Delaloye A Ross RS, Chatziioannou AF, Stout DB,
Vill
Dahlbom M, Schelbert HR: Nitrogen- 13 a prototype dual-crystal (LSO/Nal) Kenemans P — Pijpers R
ammonia cardiac positron emission dual-head coincidence camera in Kerrou K — Grahek D
tomography in mice: effects of oncology 596 Khankaldyyan V — Chen X
clonidine-induced changes in cardiac Kikuchi T —> Nagao M
work on myocardial perfusion 110 Kabasakal L, Selcuk NA, Shafipour H, Kim B-T — Lee K-H
Ishida A —~ Kawano T Ozmen O, Onsel C, Uslu I: Treatment of Kim CW — Shin JH
Ishii K — lto H iodine-negative thyroglobulin-positive Kim JS — Lee JD
Ishimori T — Iwata M thyroid cancer: differences in outcome Kim KI — Shin JH
Ishino S — Mukai T in patients with macrometastases and Kim KM — Fujita M
Isobe S —> Nanasato M patients with micrometastases 1500 Kim KM — Zeniya T
Israce! O — Bar-Shalom R Kaim AH — Wyss M1 Kim KS — Lee JD
Israel O — Tharp K Kaiser H-J — Lipke CSA Kim M-H — Kim S
Ito H, Kanno |, Kato C, Sasaki T, Ishi K Kaji T, Kuge Y, Yokota C, Tagaya M Kim S, Chung J-K, Kang S-B, Kim M-H,
Ouchi Y, lida A, Okazawa H Inoue H, Shiga T, Minematsu K, Jeong JM, Lee DS, Lee MC: ['SF]FDG
Hayashida K, Tsuyuguchi N, Ishii K Tamaki N: Characterisation of PET as a substitute for second-look
Kuwabara Y, Senda M: Database of |'-SIT}iomazeni! distribution in a rat laparotomy in patients with advanced
normal human cerebral blood flow model of focal cerebral ischaemia ovarian carcinoma 196
cerebral blood volume, cerebral oxygen in relation to histopathological findings Kim SJ — Lee JD
extraction fraction and cerebral 64 Kim SJ — Yang HS
metabolic rate of oxygen measured by Kaji T — Tsukamoto M Kinoshita Y > Nanasato M
positron emission tomography with Kalliokoski R — Knuuti J Kinuya S, Yokoyama K, Koshida K,
QO-labelled carbon dioxide or water Kambara N — Mukai T Mori H, Shiba K, Watanabe N,
carbon monoxidaen d oxy gen: a Kanetaka H, Matsuda H, Asada T, Shuke N, Bai J, Michigishi T,
multicentre study in Japan 635 Ohnishi T, Yamashita F, Imabayashi I Tonami N: Improved survival of mice
Itoh M — Kubota K Tanaka F, Nakano S, Takasaki M bearing liver metastases of colon cancet
Ivanova A — Ponomarev V Effects of partial volume correction cells treated with a combination of
Iwata M, Kasagi K, Misaki 1 on discrimination between very early radioimmunotherapy and antiangiogenic
Matsumoto K, lida Y, Ishimori 17 Alzheimer’s dementia and controls therapy 981
Nakamoto Y, Higashi T, Saga T using brain perfusion SPECT 975 Kinuya S > Bai J
Konishi J: Comparisono f whole-body Kang JH — Chung J-K Kirchner H — Meller B
F-FDG PET Tc-MIBI SPET Kang JH — Shin JH Kirsch C-M — Samnick S
and post-therapeutic I-Na Kang S-B — Kim S Kittner C — Dunkelmann S
scintigraphy in the detection of Kang WJ, Chung J-K, So Y, Jeong JM, Kjaer A. Lebech A-M, Eigtved A.
metastatic thyroid cancer 49] Lee DS, Lee MC: Differentiation of Hojgaard L: Fever of unknown origin:
Iwata M — Matsuki 1 mediastinal FDG uptake observed in prospective comparison of diagnostic
patients with non-thoracic tumours 202 value of ‘F-FDG PET and
Jacobs F, Koole M, Goethals | Kanno I — Ito H In-granulocyte scintigraphy 622
Van de Wiele C, Ham H, Dierckx R Kanno T — Torizuka T Kleijn EMHA de — Bleeker-Rovers CP
Registration accuracy of '!°*Gd Kanoi T — Mukai 7 Kletter K — Zettinig G
transmission images of the brain 1495 Kao T — Fang Y-H Knapp WH — Meyer G-J
Jacobsson H — Pagani M Karabiyikoglu M — Mari C Knapp WH — Otto D
Jager PL — Been LB Karacalioglu AO — Ilgan S Knez A — Pirich C
Jaspers JEN — Visser JJN Karavanov A — He ¥ Knudsen GM, Karlsborg M, Thomsen G,
Jeloka TK — Das BK Karlsborg M — Knudsen GM Krabbe K, Regeur L, Nygaard T,
Jentzen W — Freudenberg LS Kartachova M — Valdés Olmos RA Videbek C, Werdelin | Imaging of
Jeong JM — Kang WJ Kasagi K — Iwata M dopamine transporters and D, receptors
Jeong JM —K im § Kataoka K — Mukai T in patients with Parkinson’s disease and
Jeong JM — Shin JH Katati M — Gomez-Rio M multiple system atrophy 1631
Jereczek-Fossa BA > Lucignani G Kato C — Ito H Knuuti J: Clinical cardiac PET in the future
Jeune NI >» Denoyer D Katoh C — Tsukamoto M 467
Johansen A, Grupe P, Veje A Kaushal D — Sarin B Knuuti J, Sundell J, Naum A, Engblom E,
Nielsen Braad P-E, Hgilund-Carlsen PI Kawakami Y — Suga K Koistinen J, Ylitalo A, Stolen KQ,
Scatter and attenuation correction Kawano T, Suzuki A, Ishida A, Kalliokoski R, Nekolla SG, Bax KEJJ,
changes interpretation of gated Takahashi N, Lee J, Tayama Y, Oka T, Airaksinen KEJ Assessment of right
myocardial perfusion imaging 1152 Yokota S, Inoue T: The clinical ventricular oxidative metabolism by
Jolkkonen J — Sohlberg A relevance of thymic fluorodeoxyglucose PET in patients with idiopathic dilated
Jong HWAM de — Bokulié 7 uptake in pediatric patients after cardiomyopathy undergoing cardiac
Jonsson (¢ > Pagani M chemotherapy 831 resynchronisation therapy 1592
Jordan MC —> Inubushi M Kawano T — Suzuki A Knuuti J — Bischof Delaloye A
Joshi U, Hoekstra OS, Boellaard R Keidar Z — Bar-Shalom R Ko S-F —N g S-H
Comans EFI, Raijmakers PGHM. Keiding S — Grénroos T Kobayashi M > Torizuka T
Pijpers RJ, Miller SD, Teule GJJ Kelbaek H — Hove JD Kocacelebi K > Argon M
Lingen A van: Initial experience with Kelion AD — Underwood SR Koch A > Dunkelmann S
Koch K-C — Lipke CSA Lai W-F — Deng W-P Coppola A, Mennuti A, Dabizzi RP,
Kodama Y — Higashi K Laloux P — Tang B-N-T Pupi A: Use of °™Tc-sestamibi gated
Kofoed KF — Hesse B Landoni C — Pelosi E SPECT to assess the influence of
Kofoed KF — Hove JD Larcos G — Hatton RL anterograde flow before primary
Koistinen J — Knuuti J Larson S — Zanzonico P coronary angioplasty on tissue salvage
Konishi J — Iwata M Larson SM — Tuttle M and functional recovery in acute
Konishi J — Mukai T Larsson SA — Pagani M myocardial infarction 1378
Konno A — Horiuchi-Suzuki K Larsson SA -> Sanchez-Crespo A Lepareur N — Garin E
Koole M — Jacobs F Lauer I — Meller B Leveque PH — Mahy P
Koral KF — Zaidi H Laug WE — Chen X Li GC — Wen B
Korner M — Reubi JC Lawson JA — Bruggemann JM Liao C-T — Ng S-H
Koshida K — Kinuya S Lazzeri E, Pauwels EKJ, Erba PA, Lim SM — Lee JD
Kotzerke J — Brogsitter C Volterrani D, Manca M, Bodei L, Lin J-C — Huang W-S
Kovalev VA — Pagani M Trippi D, Bottoni A, Cristofani R, Lin S-Z — Huang W-S
Kowalczyk JR — Cholewinski W Consoli V, PalestrCoJ , Mariani G: Lindberg G — Pagani M
Kozak J — Ptachcifiska A Clinical feasibility of two-step Lindstr6m M — Ryding E
Krabbe K — Knudsen GM streptavidin/'''In-biotin scintigraphy Ling C — Zanzonico P
Krishnamurthy GT, Krishnamurthy S, in patients with suspected vertebral Ling CC — Wen B
Watson RD: Characterization of basal osteomyelitis 1505 Lingen A van — Joshi U
hepatic bile flow and the effects of Le Jeune N — Denoyer D Lingen A van — Pijpers R
intravenous cholecystokinin on the liver, Lebech A-M — Kjaer A Lipke CSA, Kiihl HP, Nowak B,
sphincter, and gallbladder in patients Leber A — Pirich C Kaiser H-J, Reinartz P, Koch K-C,
with sphincter of Oddi spasm =8 5 Lecchi M — Bettinardi V Buell U, Schaefer WM: Validation
Krishnamurthy S —~ Krishnamurthy GT Lecloirec J — Garin E of 4D-MSPECT and QGS for
Kréssin T — Maza S Lee DS — Kang WJ quantification of left ventricular
Krug B, Willemart B, Mathieu I, Pirson AS, Lee DS — Kim S volumes and ejection fraction from
Luyx D, Sonet A, Bosly A, Vander Lee DS — Shin JH gated 9°" Tc-MIBI SPET: comparison
Borght T: Acute renal failure as the first Lee H — Yang HS with cardiac magnetic resonance
presenting sign of non-Hodgkin's Lee J — Kawano T imaging 482
lymphoma 613 Lee J — Suzuki A Liu G, He J, Dou S, Gupta S,
Kubota K, Yokoyama J, Yamaguchi K, Lee JD, Yun M, Lee JM, Choi Y, Choi Y-H, Vanderheyden J-L, Rusckowski M,
Ono S, Qureshy A, Itoh M, Fukuda H Kim JS, Kim SJ, Kim KS, Yang WI, Hnatowich DJ: Pretargeting in tumored
FDG-PET delayed imaging for the Park YN, Han K-H, Lee WJ, Yoo N, mice with radiolabeled morpholino
detection of head and neck cancer Lim SM, Park JH: Analysis of gene oligomer showing low kidney uptake
recurrence after radio-chemotherapy expression profiles of hepatocellular 417
comparison with MRI/CT 590 carcinomas with regard to Liu R-S — Deng W-P
Kubuschok B — Samnick S 'SF-fluorodeoxyglucose uptake pattern Liu R-S — Fang Y-H
Kudo H — Zeniya T on positron emission tomography 1621 Liu X — Zhang X
Kuge Y — Kaji T Lee JJS — Wu T-H Llamas-Elvira JM — Gomez-Rio M
Kuge Y — Tsukamoto M Lee JM — Lee JD Loi GL — Piga M
Kiihl HP — Lipke CSA Lee J-K, Tyan Y-S, Huang W-S: Loose D — Vermeersch H
Kuikka JT — Sohlberg A Comparison of thallium-201 SPET Lopez A — Lorenzo-Bosquet C
Kulisewsky J — Estorch M and CT/MRI in the detection of Lopez Ramirez E — Gomez-Rio M
Kung HF — Kung M-P residual/recurrent squamous cell Lopez-Hianninen E — Amthauer H
Kung M-P, Hou C, Zhuang Z-P, Cross AJ, carcinoma of the oral cavity 528 Lorenzo-Bosquet C, Navarrete M, Rubio A,
Maier DL, Kung HF: Characterization Lee K-H, Byun SS, Choi JH, Paik J-Y, Lépez A, Castell-Conesa J: Whole-body
of IMPY as a potential imaging agent Choe YS, Kim B-T: Targeting of muscle gallium uptake in a large B-cell
for B-amyloid plaques in double lacZ reporter gene expression with non-Hodgkin lymphoma _ 1452
transgenic PSAPP mice 1136 radioiodine-labelled phenylethyl-f-p- Lotz J-P — Grahek D
Kiinzi G ~ Beyer G-J thiogalactopyranoside 433 Lozano SO — Gémez-Rio M
Kusmierek J — Ptachcinska A Lee MC — Kang WJ Lucignani G, Jereczek-Fossa BA,
Kuwabara Y — Ito H Lee MC — Kim S Orecchia R: The role of molecular
Kuwert T — Deichen JT Lee MC — Shin JH imaging in precision radiation therapy
Lee M-S — Huang W-S for target definition, treatment
Labar B —~ Hui¢ D Lee WJ — Lee JD planning optimisation and quality
Labar D — Mahy P Lee WW — Yang HS control 1059, 1217
Lahorte C — Vermeersch H Lee YJ — Shin JH ucignani G — Bettinardi V
Lahorte CMM, Vanderheyden J-L, Lehikoinen P — Sutinen E ucignani G — Malesci A
Steinmetz N, Van de Wiele C, Lehmann R — Débert N uini A — De Cicco C
Dierckx RA, Slegers G: Lemke A-J — Amthauer H undqvist R — Pagani M
Apoptosis-detecting radioligands Lensu S — Sohlberg A Luthra SK — Francis DI
current state of the art and future Leoncini M, Bellandi F, Sciagra R, Luthra SK — Visvikis D
perspectives 887 Maioli M, Toso A, Sestini S, Luxen A — Couturier O
\
Luyx D — Krug B Matsunaga N > Suga K Miura K — Higashi K
Lycklama 4 Nijeholt GAB Matsunari | — Higashi K Mix M — Brink I
> Soerdjbalie Maikoe V Matsushita R — Bai J Miyagawa T — Sasajima T
Matthies A, Ezziddin S, Ulrich E-M, Miyagi E — Suzuki A
Mach RH - Clark PB Palmedo H, Biersack H-J, Bender H, Mochizuki T — Nagao M
Machulla H-J > Smyczek-Gargya B Guhlke S: Imaging of prostate cancer Mogi K — Tian M
Miicke H > Meyer G-J metastases with '*F-fluoroacetate using Moisan A — Garin E
Micke HR > Henze M PET/CT 797 Moncayo R — Gabriel M
Maecke HR > Forrer | Maudlin L — Webb M Mondal A — Sarin B
Maecke HR — Ptachcifska A Maune S — Muhle C Montandon M-L — Zaidi H
Mahoudeau J — Berthe I Mayer-Steinacker R — Schirrmeister H Montravers I > Grahek D
Mahy P. De Bast M, Leveque PH, Gillart J Maza S, Thomas A, Winzer KJ, Hiittner C Moon DH > Park S-W
Labar D, Marchand J, Gregoire V Blohmer J-U, Hauschild M, Richter M, Moon DH — Yang HS
Preclinical validation of the hypoxia Kréssin T, Geworski L, Zander A Mori H — Kinuya S
tracer 2-(2-nitroimidazol-1-yl)-N Guski H, Munz DL: Subareolar Morita H, Yokoyama |, Yamada N,
(3,3,3-|'5F jtrifluoropropy! acetamide injection of technetium-99m Uno K, Nagai R: Usefulness of
FJEF3 1263 nanocolloid yields reliable data on the ‘FDG N-ammonia PET imaging for
Maier DL — Kung M-P axillary lymph node tumour status in evaluation of the cardiac damage in
Maioli M — Leoncini M breast cancer patients with previous Churg-Strauss syndrome 1218
Maisey MN — Bedford M manipulations on the primary tumour Morita K — Matsuki 1
Malbert C — Garin I a prospective study of 117 patients 671 Mortelmans | > Van Laere K
Malesci A, Balzarini L, Chiti A Mazzucchelli L — Reubi JC Mortimer PS — O’ Mahony S
Lucignani G: Pancreatic cancer o1 McCready VR — Werneke | Morton KA — Clark PB
chronic pancreatitis ’ An answe! Meer JWM van der — Bleeker-Rovers CP Moser E — Brink I
from PET/MRI image fusion 1352 Meller B, Frohn C, Brand J-M, Lauer I, Motomura H — Mukai T
Manca M > Lazzeri t Schelper LF, Hof K von, Kirchner H, Mrsic M — Huic D
Manni ¢ > Schillaci O Richter E, Baehre M: Monitoring of a Mueller-Brand J — Forrer I
Mansi L: From the magic bullet to an new approach of immunotherapy with Mueller-Schauenburg W — Reimold M
etiectt ve therapy: the peptide experience allogenic In-labelled NK cells in MuhleC , Brenner W, Siidmeyer M, Hoft S.,
1393 patients with renal cell carcinoma 403 Galalae R, Czech N, Biederer J,
Marchand J — Mahy P Mena E, Camacho V, Estorch M, Fuertes J, Ahn JM, Maune S, Henze I CT-guided
Mari C, Karabiyikoglu M, Goris MI Flotats A, Carrio I mmT depreotide lymphoscintigraphy in patients with
Tait JF, Yenari MA, Blankenberg FG scintigraphy of bone lesions in patients squamous cell carcinoma of the head
Detection of focal hypoxic ischemi with lung cancer 1399 and neck: a feasibility study 940
injury and neuronal stress in a rodent Mena E — Camacho V Mukai T, Nohara R, Ogawa M, Ishino S,
model of unilateral MCA Mena E — Estorch M Kambara N, Kataoka K, Kanoi T,
occlusion/repertusion using radiolabeled Menger MD — Samnick S Saito K, Motomura H, Konishi J,
innexin V Mennuti A — Leoncini M Saji H 4 catheter-based radiation
Mariani G Menzel ( >» Doébert N detector for endovascular detection
Mariotti S Mervillie K — Vermeersch H of atheromatous plaques 1299
Marjamiki P — Grénroos T Messa C — Pelosi I Miiller SP — Freudenberg LS
Marotta G — De Cicco ¢ Metz S — Daldrup-Link HI Mulligan R —V isvikis D
Martinez del Valle Torres D Meyer C — Hesse B Munz DL — MazaS
>»G omez-Rio M Meyer GJ — Otto D Murakami Y, Takamatsu H, Taki J
Martinez-Duncker (¢ > Hurtado-L6pez LM Meyer G-J, Miicke H, Schuhmacher J Tatsumi M, Noda A, Ichise R, Tait JI
Martinez-Duncker | >» Hurtado-Lopez LM Knapp WH, Hofmann M: ®Ga-labelled Nishimura S: '*F-labelled annexin \
Martin WH > Tharp K DOTA-derivatised peptide ligands a PET tracer for apoptosis imaging 469
Maschauer S >» Deichen JI 1097 Murase K — Nagao M
Mason JC > Webb M Michalski A > Plachcinska A Murata R —G rénroos T
Mather SJ > Francis RJ Michels J-J > Berthe I Murohara T — Nanasato M
Mathieu | > Krug B Michigishi 1 > Bai J
Matsuda H >» Kanetaka H Michigishi 1 > Kinuya S Nagabhushan S — Das BK
Matsuda H — Takeuchi R Miederer M > Beyer G-J Nagai R — Morita H
Matsuki T, Tamaki N, Nakata T, Doi A Migliorini A — Sciagra R Nagao M, Sugawara Y, Ikeda M,
Takahashi H, Iwata M, Sakamoto 7 Miki H — Nagao M Fukuhara R, Hokoishi K, Murase K,
Yamauchi K, Shimazaki M, Morita K Mikotajczak R — Ptachcifska A Mochizuki T, Miki H, Kikuchi 7
Shimamoto K: Prognostic value Miller SD — Joshi | Heterogeneity of cerebral blood flow
of fatty acid imaging in patients with Minematsu K — Kaji 1 in frontotemporal lobar degeneration
angina pectoris without prior Minn H — Grénroos T and Alzheimer’s disease 162
myocardial infarction: comparison with Minn H — Sutinen I Nakada K — Tsukamoto M
stress thallium imaging 1585 Minoshima S — Tang B-N-T Nakagami Y — Suzuki A
Matsumoto K — Iwata M Misaki T — Iwata M Nakamoto Y — Iwata M
Matsumoto T — Suga K Mitterhauser M — Zettinig G Nakamura F — Torizuka T
Nakano H — Fujimoto S Mortimer PS, Purushotham AD, Park S-W — Yang HS
Nakano S — Kanetaka H Peters AM: Finding an optimal method Park YN — Lee JD
Nakasone Y — Tian M for imaging lymphatic vessels of the Parodi G — Sciagra R
Nakata T — Matsuki T upper limb 555 Parving H-H — Hesse B
Nanasato M, Hirayama H, Ando A, Isobe S, Ortega M — Vidal-Sicart S Pauwels EKJ — Lazzeri E
Nonokawa M, Kinoshita Y, Nanbu I, Ortiz V — Ponce J Pauwels EKJ — Verkooijen RBT
Yokota M, Murohara T: Incremental Ott K — Stahl A Pauwels S — Helisch A
predictive value of myocardial Otto D, Boerner AR, Hofmann M, Pedley RB — Francis RJ
scintigraphy with '*31-BMIPP in Brunkhorst T, Meyer GJ, Petrich T, Pelger RCM — Soerdjbalie-Maikoe V
patients with acute myocardial Scheumann GF, Knapp WH: Pellegrino T — Imbriaco M
infarction treated with primary Pre-operative localisation of Pelosi E, Messa C, Sironi S, Picchio M,
percutaneous coronary intervention hyperfunctional parathyroid tissue Landoni C, Bettinardi V, Gianolli L,
1512 with ''C-methionine PET 1405 Del Maschio A, Gilardi MC, Fazio F
Nanbu I — Nanasato M Ouchi Y — Ito H Value of integrated PET/CT for lesion
Narula J — Estorch M Ouchi Y — Torizuka T localisation in cancer patients:
Naum A — Knuuti J Oyen WJG — Bleeker-Rovers CP a comparative study 932
Navarrete M — Lorenzo-Bosquet C Ozdemir O — Erselcan T Perek N — Denoyer D
Nekolla SG — Knuuti J Ozdemir S — Erselcan T Perez S — Prigent-Le Jeune F
Nekolla SG — Pirich C Ozguven MA — Iigan S Perkins AC — Birchall JD
Neri D — Brack SS Ozkilic H ~ Argon M Pertejo V — Ponce J
Neumann RD — He Y Ozmen O — Kabasakal L Peters AM: The kinetic basis of glomerular
Ng S-H, Chang JT-C, Chan S-C, Ko S-F, Ozturk E — Ilgan S filtration rate measurement and new
Wang H-M, Liao C-T, Chang Y-C, concepts of indexation to body size
Yen T-C: Nodal metastases of Pabuscu Y — Ilgan S 137
nasopharyngeal carcinoma: patterns of Pacini F, Burroni L, Ciuoli C, Di CairanoG , Peters AM — O’ Mahony S
disease on MRI and FDG PET 1073 Guarino E: Management of thyroid Petretta M, Storto G, Acampa W,
Niederle B — Zettinig G nodules: a clinicopathological, Sansone V, Evangelista L, Spinelli L,
Nielsen Braad P-E — Johansen A evidence-based approach 1443 Cuocolo A: Relation between wall
Nielsen FS — Hesse B Padhy AK — Sundram F thickening on gated perfusion SPECT
Nishimura S —> Murakami Y Paganelli G, De Santis R: Antibody-based and functional recovery after coronary
Nishio S — Horiuchi-Suzuki K cancer therapies: back to “polyclonals”? revascularization in patients with
Nitzsche EU — Brink I 1453 previous myocardial infarction 1599
Noda A — Murakami Y Paganelli G — Bodei L Petrich T — Otto D
Nohara R — Mukai T Paganelli G — De Cicco C Pfluger T — Hahn K
Noiret N — Garin E Pagani M, Gardner A, Salmaso D, Picchio M — Pelosi E
Nomura M — Bai J Sanchez Crespo A, Jonsson C, Pichler B — Daldrup-Link HE
Nonokawa M — Nanasato M Jacobsson H, Lindberg G, Wagner A, Piga M, Serra A, Deiana L, Loi GL,
Nowak B — Lipke CSA Hillstr6m T, Larsson SA: Principal Satta L, Di Liberto M, Mariotti S: Brain
Nowrousian MR — Freudenberg LS component and volume of interest perfusion abnormalities in patients with
Nunan TO — Barrington SF analyses in depressed patients imaged euthyroid autoimmune thyroiditis 1639
Nurmi M — Sutinen E by °°™Tc-HMPAO SPET: a Pijpers R, Buist MR, Lingen A van,
Nygaard T — Knudsen GM methodological comparison 995 Dijkstra J, Diest PJ van, Teule GJJ,
Pagani M, Kovalev VA, Lundqvist R, Kenemans P, Verheijen RHM:
Ogawa M — Mukai 1 Jacobsson H, Larsson SA, Thurfjell L: The sentinel node in cervical cancer:
Oh SJ — Park S-W A new approach for improving scintigraphy and laparoscopic gamma
Ohnishi T -> Kanetaka H diagnostic accuracy in Alzheimer’s probe-guided biopsy 1480
Oka T — Kawano T disease and frontal lobe dementia Pijpers RJ — Joshi U
Okada H — Torizuka T utilising the intrinsic properties of the Piontek G — Daldrup-Link HE
Okazawa H — Ito H SPET dataset 307 Pirich C, Leber A, Knez A, Bengel FM,
Oku T — Sasajima T Paghera B — Giubbini R Nekolla SG, Haberl R, Schwaiger M:
Onkhuudai P — Sundram f Paik J-Y — Lee K-H Relation of coronary vasoreactivity and
Ono S — Kubota K Palestro CJ — Lazzeri E coronary calcification in asymptomatic
Onsel C — Kabasakal | Palmedo H — Matthies A subjects with a family history of
Oostendorp RAJ — Daldrup-Link HE Palou JM — Vidal-Sicart S premature coronary artery disease 663
Opie LH — Hesse B Panyutin IG — He Y Pirich C — Zettinig G
Orecchia R — Lucignani G Papadopoulos T — Deichen JT Pirson AS — Krug B
Oriuchi N — Tian M Papapoulos SE — Soerdjbalie-Maikoe \ Pizzocaro C — Giubbini R
O’ Doherty MJ — Barrington SF Park JH — Lee JD Ptachcifska A, Mikotajezak R,
O’ Donoghue J — Wen B Park R — Chen X Maecke HR, Michalski A, Rzeszutek K,
O’ Donoghue J — Zanzonico P Park S-W, Hong M-K, Oh SJ, Moon DH: Kozak J, KuSmierek J: 9°°™Tc-
O’ Leary M — Birchall JD Intracoronary brachytherapy for in-stent EDDA/HYNIC-TOC scintigraphy
O’ Mahony S, Rose SL, Chilvers AJ, restenosis: will it remain a viable in the differential diagnosis of solitary
Ballinger JR, Solanki CK, Barber RW, therapy? 1219 pulmonary nodules 1005
XII
Plickinger | > Amthauer H Reinartz P — Lipke CSA in in vivo models of human pancreatic
Poethko T — HenriksenG Reischl G —~ Reimold M adenocarcinoma 532
Poffijn B — De Winter I Reischl G — Smyczek-Gargya B Sanchez Crespo A — Pagani M
Ponce J, Pons V, Sopena R, Garrigues \V Reubi JC, KOrner M, Waser B, Sanchez-Crespo A, Andreo P, Larsson SA
Ponce M, Ortiz V, Pertejo V Mazzucchelli L, Guillou L: High Positron flight in human tissues and its
Quantitative cholescintigraphy and bile expression ol peptide receptors influence on PET image spatial
abnormalities in patients with as a novel target in gastrointestinal resolution 44
acalculous biliary pain 1160 stromal tumours 803 Sandler MP — Tharp K
Ponce M > Ponce J Richter E — Meller B Sansone V — Petretta M
Poniatowicz-Frasunek f > Cholewinski W Richter M — Maza S Sarin B, Chugh PK, Kaushal D, Soni NI
Ponomarev V, Doubrovin M, Serganova | Rigo P — Couturier O Sawroop K, Mondal A, Bhatnagar A
Vider J, Shavrin A, Beresten T Rijk PP van — Bokulié T Sodium bicarbonate-augmented stress
Ivanova A, Ageyeva L, Tourkova V, Robbins R — Tuttle M thallium myocardial scintigraphy 475
Balatoni J, Bornmann W, Blasberg R Robert A — Tang B-N-T Sasajima T, Miyagawa T, Oku T
Gelovani Tjuvajev J: A novel Rocca P — Bodei I Gelovani JG, Finn R, Blasberg R
triple-modality reporter gene for Rodriguez-Fernandez A — Gomez-Rio M Proliferation-dependent changes in
whole-body fluorescent Rohlfing T — Amthauer H amino acid transport and glucose
bioluminescent, and nucleat Roivainen A — Sutinen E metabolism in glioma cell lines 1244
noninvasive imaging 740 Romeike BFM — Samnick S Sasaki T — Ito H
Pons F — Vidal-Sicart S Roos KP — Inubushi M Sato A — Hesse B
Pons V — Ponce J Résch F — Schreckenberger M Satta L — Piga M
Popper! G, Gotz C, Rachinger W Rose SL — O'Mahony S Savi A — Bettinardi V
Gildehaus F-J, Tonn J-C, Tatsch K Rosén I — Ryding E Sawroop K — Sarin B
Value of O-( F jfluoroethy!) Ross RS — Inubushi M Schachinger V — Dobert N
tyrosine PET for the diagnosis Rossini P — Giubbini R Schaefer WM — I ipke CSA
of recurrent zhoma 1464 Roucoux A > Garin E Schelbert HR — Inubushi M
Postmus PE — Herder GJ Roxburgh JC > Barrington SI Schelper LF — Meller B
Pradhan PK — Das BK Ruan S > Zanzonico P Scheumann GF — Otto D
Prante O — Deichen JT Rubio A — Lorenzo-Bosquet C Schillaci O, Danieli R, Manni ¢
Prigent-Le Jeune F, Dubois F, Perez S Rudelius M — Daldrup-Link HE Capoccetti F, Simonetti G
Blond S, Steinling M: Technetium-99m Ruf J — Amthauer H lechnetium-99m-labelled red blood cell
sestamibi brain SPECT in the follow-up Ruhland S — Brink | imaging in the diagnosis of hepatic
of glioma for evaluation of response to Rull R — Vidal-Sicart S haemangiomas: the role of SPECT/CT
chemotherapy: first results 714 Rummeny EJ — Daldrup-Link HE with a hybrid camera 1011
Prisco G — De Cicco ¢ Ruotsalainen U — Sohlberg A Schirrmeister H, Arslandemir C,
Prvulovich EM — Underwood SR Rusckowski M — Liu G Glatting G, Mayer-Steinacker R
Puig S — Vidal-Sicart S Ryding E, Lindstrém M, Bradvik B, Bommer M, Dreinhéfer K, Buck A,
Pup: A — Leoncini M Grabowski M, Bosson P. Hetzel M: Omission of bone scanning
Pupi A — Sciagra R lriskman-Bendz L, Rosén I A new according to staging guidelines
Purushotham AD — O'Mahony S model for separation between brain leads to futile therapy in non-small cell
dopamine and serotonin transporters lung cancer 964
Qureshy A — Kubota K in '-I1-6-CIT SPECT measurements Schlag PM > Amthauer H
normal values and sex and age Schlegel J > Daldrup-Link HI
Rachinger W > POpperl G dependenc e 1114 Schmidt C > Deichen JT
Radman | — Huic D Rzeszutek K — Ptachcifska A Schneider R > Zanzonico P
Rahman L — Webb M Schneider | > Amthauer H
Raijmakers PGHM — Joshi | Sabido O > Denoyer D Schneider W — Reinartz P
Rame J-P — Berthe I Saga T > Iwata M Schottelius M — Henriksen G
Rau B — Amthauer H Saito K > Mukai 7 Schreckenberger M, Hagele S,
Reber H — Helisch A Saji H > Horiuchi-Suzuki K Siessmeier T, Buchholz H-G,
Regeur L — KnudsenG M Say H >» Mukai T Armbrust-Henrich H, Rosch F,
Reimold M, Mueller-Schauenburg W Sakamoto T > Matsuki 7 Griinder G, Bartenstein P, Vogt T
Becker GA, Reischl G, Dohmen BM Salmaso D > Pagani M The dopamine D, receptor ligand
Bares R: Non-invasive assessment Salvatore M > Aloj I ‘F-desmethox yfallypride: an
of distribution volume ratios and Samama G > Berthe I appropriate fluorinated PET tracer for
binding potential: tissue heterogeneity Samnick S, Romeike BFM, Kubuschok B, the differential diagnosis of
and interindividually averaged Hellwig D, Amon M, Feiden W, parkinsonism 1128
time-activity curves 564 Menger MD, Kirsch C-M Schuemichen C — Dunkelmann S
Reinartz P. Wieres F-J Schneider W p-|'**L|iodo-L-phenylalanine for Schuhmacher J > Henze M
Schur A, Buell U: Side-by-side reading detection of pancreatic cancer: basic Schuhmacher J > Meyer G-J
of PET and CT scans in oncology investigations of the uptake Schulthess GK von: Maximising the benefit
which patients might profit from characteristics in primary human of integrated PET/CT: the road ahead
integrated PET/CT? 1456 pancreatic tumour cells and evaluation 1462